Contacts

Press Office

Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended and more.

Categories

18 Apr 2024

NEW RESEARCH: SCOPING REVIEW OF ORAL NICOTINE POUCHES FURTHER SUBSTANTIATES THEIR GROWING TOBACCO HARM REDUCTION POTENTIAL

11 Sep 2023

IMPERIAL SCIENTISTS ATTENDING EUROTOX, CORESTA AND TSRC THIS AUTUMN

15 Jun 2023

NEW CLINICAL RESEARCH: PULZE+ID DEMONSTRATE CREDENTIALS AS A VIABLE SMOKING ALTERNATIVE

11 May 2023

NEW STUDY: REDUCED LEVELS OF TOXICANTS IN BLU 2.0 VAPES ARE REFLECTED IN SUBSTANTIALLY REDUCED CELL TOXICITY, IN-VITRO

6 Mar 2023

NEW RESEARCH: BEHAVIORAL STUDIES SUGGEST VAPING MYBLU ISN’T A GATEWAY TO SMOKING CIGARETTES, AND VAPING HIGHER STRENGTH E-LIQUIDS DOESN’T LEAD TO INCREASED USER DEPENDENCE 

23 Jan 2023

CORESTA APPOINTMENTS FOR IMPERIAL BRANDS

7 Jun 2022

Clinical study demonstrates significant reductions in exposure to harmful chemicals vaping myblu compared to combustible cigarettes

23 May 2022

Vaping nicotine salts more closely replicates cigarette-like pulmonary delivery of nicotine compared to traditional freebase nicotine, according to new research

8 Mar 2022

Pre-clinical assessment of tobacco-free nicotine pouches demonstrates reduced in-vitro toxicity compared to combustible cigarette smoke

18 Feb 2022

Research shows heated tobacco and vape NGP display reduced cardiotoxicity potential relative to combustible cigarette smoke